-
Functional Areas
- Audit and Investigations
-
Capacity development and transition, strengthening systems for health
- A Strategic Approach to Capacity Development
- Capacity Development and Transition - Lessons Learned
- Capacity development and Transition Planning Process
- Capacity Development and Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Functional Capacities
- Interim Principal Recipient of Global Fund Grants
- Legal and Policy Enabling Environment
- Overview
- Resilience and Sustainability
- Transition
-
Financial Management
- CCM Funding
- Grant Closure
- Grant Implementation
- Grant-Making and Signing
- Grant Reporting
- Overview
- Sub-recipient Management
-
Grant closure
- Overview
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
- Terminology and Scenarios for Grant Closure Process
- Human resources
- Human rights, key populations and gender
-
Legal Framework
- Agreements with Sub-sub-recipients
- Amending Legal Agreements
- Implementation Letters and Management Letters
- Language of the Grant Agreement and other Legal Instruments
- Legal Framework for Other UNDP Support Roles
- Other Legal and Implementation Considerations
- Overview
- Project Document
- Signing Legal Agreements and Requests for Disbursement
-
The Grant Agreement
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Conditions
- Grant Confirmation: Face Sheet
- Grant Confirmation: Limited Liability Clause
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation
- UNDP-Global Fund Grant Regulations
- Monitoring and Evaluation
- Principal Recipient Start-Up
-
Procurement and Supply Management
- Development of List of Health Products and Procurement Action Plan
- Distribution and Inventory Management
- Overview
- Price and Quality Reporting (PQR) System
- Procurement of Non-health Products and Services
- Procurement of Pharmaceutical and Other Health Products
- Quality Control
- Rational use of Medicines and Pharmacovigilance Systems
- Strengthening of PSM Services and Risk Mitigation
- UNDP Health PSM Roster
- UNDP Quality Assurance Policy and Plan
-
Reporting
- Communicating Results
- Grant Performance Report
- Overview
- Performance-based Funding and Disbursement Decision
- PR and Coordinating Mechanism (CM) Communication and Governance
- Reporting to the Global Fund
- UNDP Corporate Reporting
-
Risk Management
- Common Risks Identified in Global Fund Programmes
- Global Fund Risk Management
- Introduction to Risk Management
- Overview
- Risk Management in High Risk Environments
- Risk Management in UNDP-managed Global Fund Grants
- Risk management in UNDP
- UNDP Risk Management in the Global Fund Portfolio
- Sub-Recipient Management
UNDP Quality Assurance Policy and Plan
UNDP Quality Assurance Policy for Health Products and Guidance on Health Products Quality Assurance in the Supply Chain
The UNDP Quality Assurance Policy for Health Products (QA Policy) was developed to assure the safety of all health products procured by UNDP. In addition to the procurement support that UNDP provides to governments in countries where it serves as interim Principal Recipient of Global Fund grants, a rapidly increasing number of governments are requesting UNDP to help strengthen national capacities and systems for the provision of health services, especially for the procurement and supply management of health products for communicable and more recently for non-communicable diseases. While for HIV, tuberculosis and malaria, the UNDP QA Policy is consistent with the Global Fund QA Policy, this UNDP policy extends to all other health products procured by UNDP beyond these three diseases.
The UNDP QA Policy covers the upstream aspects of quality assurance (QA) – sourcing and procurement – to ensure that the medicines and other health products supplied by UNDP are qualified and supplied to the recipients in accordance with international standards. It is based on WHO norms and standards for medicines and other health products and is aligned with QA policies of other UN agencies and international organizations. By detailing UNDP QA requirements for health procurement, the QA Policy represents a key document for all parties involved in procurement activities across UNDP and may also serve to guide national partners, suppliers and donors.
UNDP has also developed Guidance for UNDP Country Offices on Health Products Quality Assurance in the Supply Chain, which includes a QA Action Plan Template (Annex 1) and a Reporting Template for Quality Control Laboratory Testing (Annex 6). This guidance document provides UNDP Country Offices some information on the role they can play to maintain and control the quality of health products in national supply chains, from the delivery point in country up to the end user, and in collaboration with the national pharmaceutical regulatory authorities. It also details a methodology to elaborate QA actions plans that will ensure that the funds available for QA are utilized to the best impact possible. It complements the UNDP QA Policy by focusing on downstream QA measures. The guidance covers the following areas:
UNDP Country Office responsibilities and funding for QA and QA plans
Upstream QA considerations:
- Selection
- Supply Sourcing & regulatory aspects
- International freight and transit requirements
In-country supply chain QA aspects:
- Receiving
- Storage
- Distribution
Quality monitoring
- Quality control of health products
Other QA considerations:
- Pharmaceutical waste management
- Pharmacovigilance
- Surveillance and monitoring for substandard and falsified medical products
- Rational medicines use
It is also important to note that when a UNDP Country Office is a Principal Recipient of Global Fund grants, it must adhere to the “Guide to Global Fund Policies on Procurement and Supply Management of Health Products”, which itself refers to the Global Fund’s QA policies.
Loading resources
